Bank of New York Mellon Corp boosted its stake in shares of Sarepta Therapeutics by 27.1% in the second quarter.

Source: https://www.etfdailynews.com/2023/08/07/equities-analysts-offer-predictions-for-sarepta-therapeutics-inc-s-q4-2024-earnings-nasdaqsrpt/

C M Bidwell & Associates Ltd. lifted its position in shares of Sarepta Therapeutics by 1,966.7% in the second quarter.

Source: https://www.etfdailynews.com/2023/02/19/amalgamated-bank-raises-stock-holdings-in-sarepta-therapeutics-inc-nasdaqsrpt/

Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Sarepta Therapeutics during the 1st quarter worth approximately $49,000.

Source: https://www.dailypolitical.com/2023/12/09/guidance-capital-inc-invests-208000-in-sarepta-therapeutics-inc-nasdaqsrpt.html

Needham & Company LLC Trims Sarepta Therapeutics Target Price to $82.

Source: https://www.americanbankingnews.com/2023/11/02/needham-company-llc-trims-sarepta-therapeutics-nasdaqsrpt-target-price-to-82-00.html

This is my life's work and I along with my colleagues at Sarepta will not rest until we do our part in advancing the science and developing the therapies for waiting patients.

Source: https://seekingalpha.com/article/4583155-sarepta-therapeutics-inc-srpt-q4-2022-earnings-call-transcript?source=feed_all_articles